Filter
1034
Filtered Results: 1034
Text search:
labeling
Featured
Recommendations
91
New Publications
267
Language
Document type
No document type
542
Guidelines
170
Studies & Reports
161
Manuals
75
Strategic & Response Plan
39
Fact sheets
20
Training Material
18
Brochures
2
Dashboards/Maps
2
Situation Updates
2
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
India
60
Global
47
Kenya
35
Ghana
22
Ethiopia
22
South Africa
20
Uganda
17
Nigeria
16
Nepal
15
Western and Central Europe
15
Tanzania
14
Zambia
14
Rwanda
13
Sierra Leone
12
Namibia
10
Liberia
9
Malawi
8
Zimbabwe
8
Philippines
8
Bangladesh
8
Eswatini/ Swaziland
7
Latin America and the Carribbean
6
South–East Asia Region
6
Botswana
6
Lesotho
5
Syria
5
West and Central Africa
5
Senegal
4
Africa
4
Congo, Democratic Republic of
4
East and Southern Africa
4
Russia
4
Indonesia
4
Ukraine
3
Kyrgyzstan
3
Cambodia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Paraguay
3
North America
3
Eastern Europe
3
Moldova
3
Myanmar / Burma
3
Tajikistan
2
China
2
Kazakhstan
2
Peru
2
USA
2
Haiti
2
Venezuela
2
Germany
2
Western Pacific Region
2
United Kingdom
2
Bosnia and Herzegovina
2
Mali
2
Madagascar
2
Pakistan
2
Thailand
1
Turkey
1
Australia
1
Gambia
1
Chile
1
Cameroon
1
Albania
1
Canada
1
Fiji
1
Afghanistan
1
Guinea-Bissau
1
Turkmenistan
1
Portugal
1
Spain
1
Israel
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Brazil
1
Sudan
1
Central African Republic
1
Bhutan
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Countries
368
Public Health
83
Clinical Guidelines
81
Key Resources
62
Pharmacy & Technologies
48
Women & Child Health
43
Capacity Building
21
Toolboxes
Pharmacy
77
Mental Health
71
COVID-19
67
NCDs
44
HIV
43
Planetary Health
41
AMR
36
Disability
34
TB
32
NTDs
31
Ebola & Marburg
29
Rapid Response
28
Caregiver
24
Specific Hazards
19
Global Health Education
12
Conflict
11
Refugee
10
Cholera
6
Zika
4
Polio
4
Natural Hazards
3
Social Ethics
2
Health Financing Toolbox
2
Malaria
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala...
Food environments are usually defined as the settings with all the different types of
food made available and accessible to people as they go about their daily lives.
That is, the range of food in supermarkets, small retail outlets, wet markets, street
food stalls, coffee shops, tea houses, s...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop...
This interim guidance to national health authorities and blood transfusion services outlines the steps required to collect convalescent whole blood (CWB) or plasma (CP) from Ebola virus disease (EVD) recovered patients for transfusion to patients with early EVD, as an empirical treatment modality.
...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Externalising disorders
Chapter D.2
he aetiology of asthma and allergic disease remains poorly understood, despite considerable research. The International Study of Asthma and Allergies in Childhood (ISAAC), was founded to maximize the value of epidemiological research into asthma and allergic disease, by establishing a standardized m...
25th March, 2020
(In suppression earlier guidelines upload at CPCB website on 19/03/2020)
